LUNG CONNECT is an international group of experts in the field of thoracic oncology and is an initiative of COR2ED. The group discusses the latest scientific and clinical insights, identifies educational needs, and develops educational programmes to support healthcare professionals globally to provide the best possible care to their patients.
LUNG CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer, Pierre Fabre Laboratories, Boehringer Ingelheim, Eisai Pharma AG, Revolution Medicines, and AstraZeneca.
Experts join us at ESMO 2026 to share their insights on new data on GI, liver, lung, breast and GU cancers
Insights from patients and caregivers
Expert insights on how the latest evidence is shaping clinical practice
Experts join us at ESMO 2026 to share their insights on new data on GI, liver, lung, breast and GU cancers
Expert insights on the latest data
Experts join us at ESMO 2025 to share their views on new data on GU, lung, breast, gynecological and upper GI cancers
Renowned medical experts share their insights into new data presented at ESMO 2024